Page 6 - Drug Manufacturers
Coronavirus: UP govt reopens 5,200 industrial units during lockdown
905 flour mills, 419 oil mills and 235 pulses mills were currently functional in the state so that there is no shortage of essential food items
 "Coronavirus: UP govt reopens 5,200 industrial units during lockdown")
Coronavirus outbreak: Pharma market grows 9% in March due to panic buying
Cardio-diabetic and respiratory segments clock robust growth
 "Coronavirus outbreak: Pharma market grows 9% in March due to panic buying")
Coronavirus: ITC repurposes Himachal perfume plant to produce sanitisers
The move follows ITC temporarily stopping manufacture of cigarettes - its main revenue earner - as well as production of non essential items
 "Coronavirus: ITC repurposes Himachal perfume plant to produce sanitisers")
Govt allows doorstep delivery of drugs to help citizens under lockdown
The health ministry invoked section 26B of the Drugs and Cosmetics Act, 1940 to facilitate the doorstep delivery of drugs to consumers
 "Govt allows doorstep delivery of drugs to help citizens under lockdown")
Govt approves Rs 13K-crore package to boost bulk drugs manufacture
Industry feels India first needs to tap existing capacity before setting up new drugs parks
Govt sanctions Rs 1,850 cr to ensure better drug monitoring systems
A significant share of this money will go into upgrading the Sugam portal - the e-governance solution for CDSCO.
 "Govt sanctions Rs 1,850 cr to ensure better drug monitoring systems")
Demand for chronic illness medicines rising faster than acute drugs: Report
Long-term treatments like diabetes, high blood pressure and lipid-lowering drugs are classified into the chronic category
 "Demand for chronic illness medicines rising faster than acute drugs: Report")
Govt reviews industry's demands to implement changes in drug price policy
A senior government official said the industry has been requesting for an amendment to allow them to implement the price change from the next batch.
 "Govt reviews industry's demands to implement changes in drug price policy")
PharmEasy, 1mg, Netmeds look to power their brands, build trust in business
According to many reports, e-pharmacies have spent well over their capacities in building their brands
 "PharmEasy, 1mg, Netmeds look to power their brands, build trust in business")
Indian pharmaceutical companies spread business to avoid regulatory ire
Increased USFDA import alerts could be reason for finding alternative sites
 "Indian pharmaceutical companies spread business to avoid regulatory ire")
Restart unannounced inspections of drug units in India, China: US senator
The chairman of the Senate Finance Committee said this was needed as these facilities provided most of the ingredients for production inside the US
 "Restart unannounced inspections of drug units in India, China: US senator")
Active pharmaceutical ingredients focus helps drug firms offset slowdown
Besides captive consumption, the company also supplies APIs to external customers across international markets
 "Active pharmaceutical ingredients focus helps drug firms offset slowdown")
As price pressure mounts, pharma companies tap analytics to cut costs
Cipla is the first company in the Asia Pacific to upgrade to a cloud-based pharmacovigilance solution
 "As price pressure mounts, pharma companies tap analytics to cut costs")
India taking several steps to reduce dependence on imports of API
Domestic drug manufacturers has seen a sharp spike in the prices of these raw materials after the Chinese government shut down many API producing plants owing to environmental concerns
 "India taking several steps to reduce dependence on imports of API")
